Elgethun Capital Management’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-544
| Closed | -$6.47K | – | 157 |
|
|
2023
Q4 | $6.47K | Sell |
544
-450
| -45% | -$5.35K | ﹤0.01% | 153 |
|
|
2023
Q3 | $6.36K | Hold |
994
| – | – | ﹤0.01% | 157 |
|
|
2023
Q2 | $8.25K | Buy |
994
+290
| +41% | +$2.41K | ﹤0.01% | 157 |
|
|
2023
Q1 | $3.22K | Sell |
704
-776
| -52% | -$3.55K | ﹤0.01% | 130 |
|
|
2022
Q4 | $9.17K | Buy |
1,480
+150
| +11% | +$929 | ﹤0.01% | 124 |
|
|
2022
Q3 | $9K | Hold |
1,330
| – | – | ﹤0.01% | 119 |
|
|
2022
Q2 | $18K | Buy |
+1,330
| New | +$18K | 0.01% | 116 |
|